Bryan, Garnier & Co Stock Recommendations and Price Targets

This is a list of recent ratings by Bryan, Garnier & Co.

Date	Company Name	Action	Current Price	Price Target	Rating
11/7/2024	NKLAQ Nikola	Downgrade	$0.00		Buy ➝ Neutral
5/16/2024	NKLAQ Nikola	Initiated Coverage	$0.00	$30.00	Buy
9/14/2023	MLTX MoonLake Immunotherapeutics	Downgrade	$16.00		Buy ➝ Neutral
5/5/2023	TVTX Travere Therapeutics	Upgrade	$33.00		Sell ➝ Neutral
3/24/2023	IMCR Immunocore	Initiated Coverage	$33.00	$16.00	Buy
3/24/2023	IMTX Immatics	Initiated Coverage	$10.00	$16.00	Buy
3/17/2023	CRSP CRISPR Therapeutics	Initiated Coverage	$51.00	$70.00	Buy
3/17/2023	AUTL Autolus Therapeutics	Initiated Coverage	$1.00	$5.00	Buy
3/17/2023	CLLS Cellectis	Initiated Coverage	$4.00	$6.00	Buy